Case study

Competitive Insights into API & Intermediates Market and Indian CDMO Capabilities

Explore expert insights into the API and intermediates market, including competitive dynamics and sourcing strategies. Learn about the commercial excellence and R&D capabilities of Indian CDMO players for strategic decision-making.

Competitive Insights into API & Intermediates Market and Indian CDMO Capabilities
  • Europe
  • India
  • Asia
  • CDMO
  • Pharma

CHALLENGE

Our client, one of the leading consulting firms, approached us to connect with professionals from FDF (Finished Dosage Form) pharmaceutical manufacturers and Indian CDMO (Contract Development and Manufacturing Organization) players. The key topics that they would like to discuss included understanding the competitive landscape for API (Active Pharmaceutical Ingredients) and intermediates, sourcing strategies, commercial excellence, R&D capabilities, and competitive positioning.

BTHT APPROACH

BTHT team undertook a focused strategy to identify and screen experts who could provide valuable insights into the pharmaceutical and CDMO sectors. Their research ensured that the selected experts had the requisite expertise and were aligned with the project’s objectives. The BTHT portfolio that were prepared and shared with the client in a short time included:

  • Director-CMO Management
  • Business Development Directors
  • Procurement Directors
  • Business Integration Lead
  • Global Sourcing Manager
  • Project Manager API
  • Global Third Party Chemicals Manager

Our team facilitated the connections and supported the consultation process to ensure smooth and productive discussions.

OUTCOME

The targeted approach of BTHT enabled the client to gain critical insights into the competitive landscape for APIs and intermediates, as well as the commercial and R&D capabilities of Indian CDMO players. The client was able to refine their strategies, leading to well-informed strategic decisions and successful project outcomes.

Get in touch

Let's talk about your project

Reach our CEO Alexis Capelle directly or send us a message — we typically reply within one business day.